Science Explorer Back to mapMap
Discussion
Researcher · Acuitas Therapeutics (Canada) · Canada

Ying K. Tam

Ying K. Tam publishes mostly in Molecular Biology, Immunology and Infectious Diseases, on topics such as RNA Interference and Gene Delivery, Immunotherapy and Immune Responses and SARS-CoV-2 and COVID-19 Research.

ORCID 0000-0002-4083-5251 OpenAlex
World rank
#14,653
of 7,710,434 ranked researchers
Rank in Canada
#286
of 183,316
Works
192
Citations
23k
Citations per work
119.5
h-index
65
i10-index 116Top 1.5% in Molecular Biology
Ying K. Tam

What does Ying K. Tam research?

Ying K. Tam's work is mostly in Biochemistry, Genetics and Molecular Biology (33%), Immunology and Microbiology (26%), Medicine (16%).

Life Sciences: 114 works · 59.4% of their workBiochemistry, Genetics and Molecular Biology: 64 works · 33.1% of their workMolecular Biology: 55 works · 28.6% of their workGenetics: 9 works · 4.5% of their workImmunology and Microbiology: 50 works · 26.3% of their workImmunology: 44 works · 22.7% of their workVirology: 7 works · 3.6% of their workEverything else: 48 works · 24.9% of their workHealth Sciences: 30 works · 15.7% of their workMedicine: 30 works · 15.7% of their workInfectious Diseases: 22 works · 11.2% of their workEpidemiology: 9 works · 4.5% of their workTHEIR WORKYing K. Tam192works
Life Sciences59%Health Sciences16%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology6433.1%
    2. Immunology and Microbiology5026.3%
  2. Everything else4824.9%
    1. Medicine3015.7%
  1. 1Molecular Biology29% of their works
  2. 2Immunology23% of their works
  3. 3Infectious Diseases11% of their works
  4. 4Epidemiology4% of their works
  5. 5Genetics4% of their works
  6. 6Virology4% of their works

Research topics

Which keywords describe Ying K. Tam's research?

The keywords of their largest research topics: Gene Therapy, Immunity, RNA Interference, siRNA Delivery, Vaccine, Cancer Immunotherapy, Dendritic Cells and Coronavirus.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Gene Therapy982 topics
  2. Immunity912 topics
  3. RNA Interference761 topic
  4. siRNA Delivery761 topic
  5. Vaccine713 topics
  6. Cancer Immunotherapy561 topic
  7. Dendritic Cells561 topic
  8. Coronavirus522 topics
  9. Immune Response362 topics
  10. SARS-CoV-2351 topic
  11. spike protein351 topic
  12. NK Cell Recognition241 topic
  13. Natural Killer Cells241 topic
  14. AAV221 topic
  15. DNA nanotechnology221 topic
  16. Self-Assembly221 topic
  17. Viral Vectors221 topic
  18. AIDS191 topic
  19. HIV191 topic
  20. Circovirus171 topic
  21. Porcine Reproductive and Respiratory Syndrome Virus171 topic

Where does Ying K. Tam work?

Ying K. Tam's main affiliation in the publication record is Acuitas Therapeutics (Canada), Canada.

How many publications and citations does Ying K. Tam have?

OpenAlex counts 192 works and 22,935 citations for Ying K. Tam, an h-index of 65, ranking #14,653 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ying K. Tam. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.